Jee Hyun Kim

Associate Professor

Deakin University

Australia

Research Interests

Explore related searches

Professors in Australia

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Dr. Jee Hyun Kim is an Associate Professor at Deakin University in Australia. His research focuses on areas such as atypical psychosis, bipolar disorder, schizophrenia, and methamphetamine use disorder. He has recently published articles addressing drug discovery challenges, neuroprotection strategies, and the underlying mechanisms in neuropsychiatric conditions.

Articles (19)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Collaborators (9)

Trygve B. Leergaard

Professor

University of Oslo

NORWAY

View details

Olivia M. Dean

Deakin University

AUSTRALIA

View details

Ken Walder

AUSTRALIA

View details

Andrew Lawrence

Florey Institute of Neuroscience and Mental Health

AUSTRALIA

View details

Laura Gray

Deakin University

AUSTRALIA

View details

Jason Yuen

Southmead Hospital

UNITED KINGDOM

View details

Lana J. Williams

Deakin University

AUSTRALIA

View details

Yuta Kajiyama

Associate professor/Lecturer

Kawasaki Medical School

JAPAN

View details

Yoshiyuki Nishio

Professor

Osaka University

JAPAN

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Jee Hyun Kim

Research Interests

Explore related searches

Contact this professor

About

Articles (19)

Atypical Psychosis in Parkinson Disease

The Drug Discovery Drought in Bipolar Disorder: Barriers and Solutions

New hope for individuals with schizophrenia: A transdisciplinary research platform to discover and translate novel treatments

Effect of antipsychotics on the focal adhesion pathway

Adolescent vulnerability to methamphetamine: Dose-related escalation of self-administration and cue extinction deficits

Genes, Cognition, and Their Interplay in Methamphetamine Use Disorder

The developing mouse dopaminergic system: Cortical-subcortical shift in D1/D2 receptor balance and increasing regional differentiation

The potential of baicalin to enhance neuroprotection and mitochondrial function in a human neuronal cell model

Network-based drug repurposing for schizophrenia

CREB Binding at the Zfp189 Promoter Within Medium Spiny Neuron Subtypes Differentially Regulates Behavioral and Physiological Adaptations Over the Course of Cocaine Use.

Metformin is Protective Against the Development of Mood Disorders.

Past and current drug repurposing clinical trials to treat cognition in methamphetamine use: a scoping review of pharmacotherapy candidates

Repurposing Drugs via Network Analysis: Opportunities for Psychiatric Disorders

Integrative Analyses of Transcriptomes to Explore Common Molecular Effects of Antipsychotic Drugs

Effects of Psychotropic Drugs on Ribosomal Genes and Protein Synthesis

Sex-dependent effects of chronic exercise on cognitive flexibility but not hippocampal Bdnf in aging mice

DOPAMAP, high-resolution images of dopamine 1 and 2 receptor expression in developing and adult mouse brains.

Deep Brain Stimulation for Addictive Disorders—Where Are We Now?

Co-Expression Networks Unveiled Long Non-Coding RNAs as Molecular Targets of Drugs Used to Treat Bipolar Disorder

Collaborators (9)

Trygve B. Leergaard

Olivia M. Dean

Ken Walder

Andrew Lawrence

Laura Gray

Jason Yuen

Lana J. Williams

Yuta Kajiyama

Yoshiyuki Nishio

Make your next move.